Fundraising FoxRelievant Medsystems
Redwood City, US · Delaware corporation · 6 known investors
Find your way into Relievant Medsystems
Sign up to see every warm intro you have to Relievant Medsystems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Relievant Medsystems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain. The procedure targets patients with chronic low back pain seeking long-term pain relief and functional improvement.
Founders & leadership
Board
Investors · 6
How we know: Canaan Partners's portfolio page · a partner's Signal profile · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Emergent Medical Partners, LLP's portfolio page · Not right? Tell us
How we know: Lightstone Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: board seat on SEC Form D · funding news · bizjournals.com · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$200.1M disclosed across 7 rounds · 2015–2023
▶$46MraisedMar 2023 · 12 investors · Other Health CareRule 506(b)
- Richard MottDirector
- Tyler BinneyDirector, Executive Officer
- Ray Baker, MDExecutive Officer
- Chris GeyenExecutive Officer
- Cynthia LuccheseDirector
- Brent AhrensDirector
- Art TaylorDirector
- Alexander SchmitzDirector
- Ross JaffeDirector
- David AmersonDirector
- Justin KleinDirector
- Jason LettmannDirector
- Offering amount
- $50M
- Amount sold
- $46M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$69.7MraisedApr 2022 · 35 investors · Other Health CareRule 506(b)
- Arthur TaylorDirector
- Alexander SchmitzDirector
- Justin KleinDirector
- Chris GeyenExecutive Officer
- Ross JaffeDirector
- Tyler BinneyExecutive Officer, Director
- Brent AhrensDirector
- Ray BakerExecutive Officer
- Jason LettmanDirector
- David AmersonDirector
- Richard MottDirector
- Offering amount
- $69.7M
- Amount sold
- $69.7M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$57.7MraisedJul 2018 · 29 investors · Other Health CareRule 506(c)
- Jason LettmanDirector
- Ray BakerExecutive Officer
- Alexander SchmitzDirector
- Richard MottDirector
- Alex DiNelloExecutive Officer
- Peter KleinDirector
- Arthur TaylorDirector
- Kevin HykesExecutive Officer, Director
- Brent AhrensDirector
- Chris GeyenExecutive Officer
- Offering amount
- $57.7M
- Amount sold
- $57.7M
- Minimum investment
- $1
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$22.2MraisedAug 2016 · 10 investors · OtherRule 506(b)
- Art TaylorDirector
- Richard MottDirector
- Brent AhrensDirector
- Alex DiNelloExecutive Officer, Director
- John RyanDirector
- Justin KleinDirector
- Jason LettmanDirector
- Offering amount
- $52.2M
- Amount sold
- $22.2M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$49.2KraisedJan 2016 · 5 investors · OtherRule 506(b)
- Alex DiNelloExecutive Officer, Director
- Richard MottDirector
- Art TaylorDirector
- Brent AhrensDirector
- Justin KleinDirector
- John RyanDirector
- Jason LettmanDirector
- Offering amount
- $49.2K
- Amount sold
- $49.2K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedDec 2015 · 5 investors · OtherRule 506(b)
- Richard MottDirector
- Justin KleinDirector
- Brent AhrensDirector
- Alex DiNelloExecutive Officer, Director
- Art TaylorDirector
- Jason LettmanDirector
- John RyanDirector
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedFeb 2015 · 6 investors · OtherRule 506(b)
- Brent AhrensDirector
- Richard MottDirector
- Justin KleinDirector
- Alex DiNelloExecutive Officer, Director
- John RyanDirector
- Art TaylorDirector
- Jason LettmanDirector
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Relievant Medsystems do?
- Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain. The procedure targets patients with chronic low back pain seeking long-term pain relief and functional improvement.
- Who are Relievant Medsystems's investors?
- Relievant Medsystems's investors include Canaan Partners, Emergent Medical Partners, LLP, Lightstone Ventures, New Enterprise Associates (NEA), Morgenthaler, Vensana Capital.
- How much funding has Relievant Medsystems raised?
- Relievant Medsystems has disclosed $200.1M raised across 7 rounds.
- Where is Relievant Medsystems headquartered?
- Relievant Medsystems is headquartered in Redwood City, US.